HyGreen Teesside is expected to fuel the development of Teesside into the UK’s first major hydrogen ‎transport hub, leading the way for large-scale decarbonization of heavy transport, airports, ports and ‎rail in the UK. (BP)
UK: Leading Hydrogen Hub

BP to Develop New Large-Scale Green Hydrogen Production Plant in UK’s Teeside

BP’s ‘HyGreen Teesside’ project will produce 60 MWe of green hydrogen by 2025 with a potential to increase the production to 500Mwe ‎by 2030. With this project and in addition to the other existing project by the company i.e. the blue hydrogen project (H2Teesside), UK’s Teesside region is all set to become the country’s leading hydrogen hub to decarbonize industry ‎and heavy transport.

Read on
At its site in Krefeld, Germany, Lanxess expands its production capacity for the active ingredient Preventol CMK. (LANXESS AG)
Single-digit Million Investment

Lanxess Expands Capacity of Microbial Active Ingredient

Lanxess is expanding its production capacity for the active ingredient Preventol CMK (chlorocresol) at the Krefeld-Uerdingen, Germany, site by around 50 percent in response to the continuing strong demand for disinfectants and industrial preservation. The specialty chemicals company has invested a single-digit million euro amount for the expansion, which will be completed still in the first quarter of 2022.

Read on
R. Stahl describes itself as a reliable partner in the LNG industry. (R. Stahl)
Integral Ex Protection for the Complete LNG Supply Chain

How to Achieve a Smooth Transition to a Climate-neutral Energy Supply

Liquefied natural gas (LNG) is characterised by its high availability at competitive conditions and a lower emission burden compared to the combustion of coal and oil. As it is highly flammable, explosion protection must be guaranteed throughout the entire value chain. R. Stahl supports this sector with explosion-protected products and systems for all process steps from natural gas extraction to liquefaction and transport, all the way through to reconversion and supply.

Read on
As a contract manufacturer, Wacker Biotech US Inc. in San Diego operates a specialized fermentation line for manufacturing and purifying plasmid DNA. (Wacker)
Biotechnology

Wacker relies on plasmid technology

The increasing number of mRNA therapies and vaccines is fuelling demand for plasmid DNA. To meet this demand, Wacker Biotech has developed a proprietary technology platform for plasmid production, which is used at the newly acquired biotech site in San Diego and offered under the name Plasmitec.

Read on